Measurement of Some Physiological Parameters of Patients with Rheumatoid Arthritis
Keywords:
Rheumatoid Arthritis, Measurement, Physiological Parameters, PatientsAbstract
Rheumatoid arthritis (RA) is a chronic, inflammatory, systemic autoimmune disease, affecting the joints with varying severity among patients. The risk factors include age, gender, genetics, and environmental exposure (cigarette smoking, air pollutants, and occupational). Many complications can follow, such as permanent joint damage requiring arthroplasty, rheumatoid vasculitis, and Felty syndrome requiring splenectomy if it remains unaddressed. This Study was carried out in AL- Zahra Hospital.(25) adult male (men) ,(35-50) years old,were divided into (2) groups .The first group contained healthy men(10) and assisted as controller group (G1) ,men in next group were with Rheumatoid arthritis(15) (G2) , .In this present study we collect samples of blood to count the serum of Total cholesterol(TC),Triglycerides(TG),High density lipoprotein (HDL)and Low density Lipoprotein (LDL) . The results revealed that : Significant increase (P<0.05) in serum TC,TG and LDL levels in G2 compared with control group (G1) , Significant decrease (P<0.05) in serum HDL levels in G2 compared with G1. . From the data of the present research , it can be determined that Rheumatoid arthritis, effect on metabolism of fats in men.
Downloads
References
American College of Rheumatology ad hoc Committee on Clinical Guidelines(2002). Guidelines for the management of rheumatoid arthritis. Arthritis Rheum;46:32846.
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, etal.(1987). The American Rheumatism Association revised criteria for the classification of rheumatoid arthritis. ArthritisRheum 1988;31:31524.
Deighton C, OMahoney R, Tosh J, Turner C, Rudolf M; (2009).Guideline Development Group. Management of rheumatoidarthritis: summary of NICE guidance. BMJ;338:7102.
Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, Zwinderman AH, Ronday HK, Han KH, Westedt ML, et al. (2005). Clinical and radiographic outcomes of four different treatment strategies inpatients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum;52:338190.
Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, GG, et al. (1998) .Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. ArthritisRheum;41:77899.
Sluka KA. Osteoarthritis and rheumatoid arthritis. In: Sluka KA, editor. (2009). Mechanisms and management of pain for thephysical therapist. Seattle: IASP Press;. p. 349360.
Arnett FC, Edworthy SM, Bloch DA et al. 1988 Revised criteria for the classification of rheumatoidarthritis. Arthr Rheum; 31: 31524.
Barton JL. 2009 Patient preferences and satisfaction in the treatment of rheumatoid arthritis with biologic therapy. Patient Prefer Adherence; 3: 33544.
Cohen M. Abatacept in focus. Internet J Rheumatol; et al. (2007). Efficacy of B-cell targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 2004; 350: 257281.
Genant HK, Peterfy CG, Westhovens R. 2008 Abatacept inhibits progression of structural damage inrheumatoid arthritis: results from the long-term extension of the AIM trial. Ann Rheum Dis; 67: 10849.
Goffe B, Cather JC. (2003). Etanercept: An overview. J Am Dermatol; 49(25 suppl): S10511.
Kavanaugh A, Cohen S, Cush JJ. (2004).The evolving use of tumor necrosis factor inhibitors in rheumatoidarthritis. J Rheumatol; 31: 18814.
Koenders MI, Joosten LAB, van den Berg WB.( 2006).Potential new targets in arthritis therapy: interleukin (IL)-17 and its relation to tumour necrosis factor and IL-1 in experimental arthritis.Ann Rheum Dis; 65(suppl iii): 2933.
Assmann G ., Schute H . (1992) . Relation of high density lipoprotein cholesterol and Triglycerides to incidence of atherosclerotic coronary disease. CTIe procam experience. Am .J, cardiol ., 70:733-737.
Baccarelli , A .; Zanobetti , Martinelli ,L . Grillio , P .; Hou , L .; Guido , G.; Mannucci , P.; Pier Alberto , A and Schwartz , J (2007) . Air pollution , smoking , and plasma homocysteine . Environ Health perspect .,115:176-181. .
Badimon, J.;Zaman,A. and Helft , G .(2004) .Acute Coronary Syndromes .Pathophysiology and preventive priorities thromb.Haemostas . J., 82:997-1008.
Bischof and Islami D.(2002). Sexual hormons .8TH phostyraduate course fortraining reproductive medicine and reproductive biology. .Department of obstetvics and gynecology Geneva University Hospital.P:1-4.
Block, J.H. and Beal, J.M.(2004). Willson and Gisvolds Textbook of Pharmaceutical Chemistry .11th ed . Lippincott Williams and Willkins : 657-660.
Bostom, A G.; Shemin, D; Baylary, p. (2000). Contrlled comparion of L-5- methyltetrahydrofolate versus folic acid for the treatment of Hyperhomocysteinemia in hemodialysis patient’s circulation. , 101: 2829-2832.
Denke, M. (2005). Weighing in before the fight: Low density lipoprotein cholesterol and non –high – density lipoprotein cholesterolversus apolipoprotein B as the best predictor for coranory heart disease and the best measure of therapy . Atheroscler. Thro. Vas. Biol., 112:3368-3377.
Ekaidem, M.S.: Akopanabiatu, M, I.: Uboh and Eka, O.U. (2007). Effect of folic acid and B12 administration on phentain induced toxicity in rats. Indian .J of Clin. Bioch. , 22(2):36-40.
Fernandez-Robredo,P.;Moy,D.;Rodriguez,J. and Garcia-Layana, A. (2005) .Vitamin C and E reduce retinal oxidative stress and nitric oxide metabolites and prevent ultrastructural alterations in povcine hypercholesterolemia. Investigative Opthalmology and Visual Science., 436:114-1146.
Finkleston, T. and Holbrok, N. (2000). Oxidants, Oxidative stress and the biology of aging .Nutrition . , 408(68):239-245
Neumann, E. et al. (2002). Local production of complement proteins in rheumatoid arthritis synovium. Arthritis Rheum. 46, 934–945.
Banda, N. K. et al. (2002).Mechanisms of effects of complement inhibition in murine collagen-induced arthritis. Arthritis Rheum. 46, 3065–3075.
Commentary: medicine, population, and tuberculosis. Int J Epidemiol. 2005; 34: 521-524
Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets. Arthritis Res Ther. 2008; 10: 205
Differences in synovial tissue infiltrates between anti-cyclic citrullinated peptide-positive rheumatoid arthritis and anti-cyclic citrullinated peptide-negative rheumatoid arthritis. Arthritis Rheum. 2008; 58: 53-60
Agca R, Heslinga SC, Rollefstad S, Heslinga M,et al. (2017).EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis.;76:17–28.
Choi HK, Seeger JD.( 2005) .Lipid profiles among US elderly with untreated rheumatoid arthritis—the Third National Health and Nutrition Examination Survey. J Rheumatol. ;32:2311–2316.
Steiner G, Urowitz MB. (2009).Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment. Semin Arthritis Rheum. ;38:372–381.
Knowlton N, Wages JA, Centola MB, Alaupovic P. (2012). Apolipoprotein-defined lipoprotein abnormalities in rheumatoid arthritis patients and their potential impact on cardiovascular disease. Scand J Rheumatol. ;41:165–169.
Schulte DM, Paulsen K, Turk K, Brandt B, Freitag-Wolf S,. (2018).Small dense LDL cholesterol in human subjects with different chronic inflammatory diseases. Nutr Metab Cardiovasc Dis. ;28:1100–1105
Park Y, Chang M (2016). "Effects of rehabilitation for pain relief in patients with rheumatoid arthritis: a systematic review". Journal of Physical Therapy Science. 28 (1): 304–8.
Lopez-Olivo MA, Amezaga Urruela M, McGahan L, Pollono EN, Suarez-Almazor ME (2015). "Rituximab for rheumatoid arthritis". The Cochrane Database of Systematic Reviews. 1: CD007356.
Singh JA, Hossain A, Tanjong Ghogomu E, Mudano AS, Tugwell P, Wells GA (2016). "Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA)". The Cochrane Database of Systematic Reviews. 11: CD012437.
Singh JA, Hossain A, Tanjong Ghogomu E, Mudano AS, Maxwell LJ, Buchbinder R, et al. (2017). "Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis". The Cochrane Database of Systematic Reviews. 3: CD012591.
Verhoef LM, van den Bemt BJ, van der Maas A, Vriezekolk JE, Hulscher ME, van den Hoogen FH, et al. (2019). "Down-titration and discontinuation strategies of tumour necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity". The Cochrane Database of Systematic Reviews. 5: CD010455.
Maxwell L, Singh JA (2009). Maxwell L (ed.). "Abatacept for rheumatoid arthritis". The Cochrane Database of Systematic Reviews (4): CD007277.
Allain , C.C.; Poon, L.S.;Chan,Chan ;C.S.G.; Richmond , Wand Fup , C.(1974).The Merk Manual of diagnostic and therapy .Merk and Co .,Clin .Chem .13:56-59.
Fossati, P;andprencipe.; L.( 1982). Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. clinical chemistry.,28 :2077-2080.
Lopez-Virella, M. F.; Stone, P.; Ellis, S. & Colwell, J. A. (1977). Cholesterol determination in high-density lipoproteins separated by three different methods.Clin. Chem.; 23:882-884.
Anderioli , T.E.; Carpenter , C.C.; Griggs, R.C.& Loscalza, J.(2004). Cecils essentials of medicine . USA., 392-399.
Denke, M. (2005). Weighing in before the fight: Low density lipoprotein cholesterol and non –high – density lipoprotein cholesterolversus apolipoprotein B as the best predictor for coranory heart disease and the best measure of therapy . Atheroscler. Thro. Vas. Biol., 112:3368-3377.
Gotto, A .M. (1992) . Lipid and lipoprotein disorders . Manual of lipid disorders . Pownall HJ (eds) . Baltimore , Williams and Wilkins CO ., pp . 95- 124.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Current Clinical and Medical Education
